The overlap between IBS and IBD – what is it and what does it mean?

Letter: the role of sub-clinical inflammation and TRPV1 in the development of IBS-like symptoms in ulcerative colitis in remission

(2013) D. Keszthelyi et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Symptoms of irritable bowel syndrome in patients with inflammatory bowel disease: examining the role of sub-clinical inflammation and the impact on clinical assessment of disease activity

(2013) J. W. Berrill et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Intestinal Permeability Defects: Is It Time to Treat?

(2013) Matthew A. Odenwald et al.   Clinical Gastroenterology and Hepatology

Glutamine and arginine improve permeability and tight junction protein expression in methotrexate-treated Caco-2 cells

(2013) Stéphanie Beutheu et al.   CLINICAL NUTRITION

Characterization of IBS-like symptoms in patients with ulcerative colitis in clinical remission

(2013) B. Jonefjäll et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D): study protocol for a randomised controlled trial

(2013) Matthew P Leighton et al.   Trials

Central Role of the Gut Epithelial Barrier in the Pathogenesis of Chronic Intestinal Inflammation: Lessons Learned from Animal Models and Human Genetics

(2013) Luca Pastorelli et al.   Frontiers in Immunology

Review article: associations between immune activation, intestinal permeability and the irritable bowel syndrome

(2012) J. Matricon et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Irritable Bowel Syndrome: Methods, Mechanisms, and Pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome

(2012) Michael Camilleri et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Risk of inflammatory bowel disease following a diagnosis of irritable bowel syndrome

(2012) Chad K Porter et al.   BMC GASTROENTEROLOGY

Experiences of patients with chronic gastrointestinal conditions: in their own words

(2012) Jennifer B McCormick et al.   Health and Quality of Life Outcomes

Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease

(2012) Geert DʼHaens et al.   INFLAMMATORY BOWEL DISEASES

Fatigue and disease-related worries among inflammatory bowel disease patients in remission; is it a reflection of coexisting IBS-like symptoms? A short report

(2012) Lars-Petter Jelsness-Jørgensen et al.   JOURNAL OF PSYCHOSOMATIC RESEARCH

Intestinal barrier function in health and gastrointestinal disease

(2012) M. Camilleri et al.   NEUROGASTROENTEROLOGY AND MOTILITY

CRF Induces Intestinal Epithelial Barrier Injury via the Release of Mast Cell Proteases and TNF-α

(2012) Elizabeth L. Overman et al.   PLoS One

Surrogate markers and clinical indices, alone or combined, as indicators for endoscopic remission in anti-TNF-treated luminal Crohn's disease

(2012) Clas-Göran af Björkesten et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Combination of Allergic Factors Can Worsen Diarrheic Irritable Bowel Syndrome: Role of Barrier Defects and Mast Cells

(2011) M Vivinus-Nébot et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Immune and nonimmune components orchestrate the pathogenesis of inflammatory bowel disease

(2011) Silvio Danese   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Prodromal Irritable Bowel Syndrome May Be Responsible for Delays in Diagnosis in Patients Presenting with Unrecognized Crohn’s Disease and Celiac Disease, but Not Ulcerative Colitis

(2011) S. M. Barratt et al.   DIGESTIVE DISEASES AND SCIENCES

Epidemiology of IBS

(2011) Rok Seon Choung et al.   GASTROENTEROLOGY CLINICS OF NORTH AMERICA

Prevalence of irritable bowel syndrome (IBS) in first-degree relatives of patients with inflammatory bowel disease (IBD)

(2011) Mariam Aguas et al.   Journal of Crohns & Colitis

Neutrophil gelatinase-associated lipocalin (NGAL) in inflammatory bowel disease: association with pathophysiology of inflammation, established markers, and disease activity

(2011) K. A. Oikonomou et al.   JOURNAL OF GASTROENTEROLOGY

Irritable Bowel Syndrome–Type Symptoms in Patients With Inflammatory Bowel Disease: A Real Association or Reflection of Occult Inflammation?

(2010) John Keohane et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Aminosalicylates and Other Anti-Inflammatory Compounds for Irritable Bowel Syndrome

(2010) Giovanni Barbara et al.   DIGESTIVE DISEASES

Reflux and irritable bowel syndrome are negative predictors of quality of life in coeliac disease and inflammatory bowel disease

(2010) Stephen M. Barratt et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Expression of the TRPV1 receptor differs in quiescent inflammatory bowel disease with or without abdominal pain

(2010) A. Akbar et al.   GUT

Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions

(2010) Lena Öhman et al.   Nature Reviews Gastroenterology & Hepatology

Stress-related modulation of inflammation in experimental models of bowel disease and post-infectious irritable bowel syndrome: Role of corticotropin-releasing factor receptors

(2009) Cornelia Kiank et al.   BRAIN BEHAVIOR AND IMMUNITY

Mucosal cytokine imbalance in irritable bowel syndrome

(2008) John Macsharry et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY